Renal Pharmacology Flashcards
Where does mannitol act?
PCT and descending limb of the LoH.
Where does acetazolamide act?
PCT
Where do loop diuretics act?
Ascending limb of the LoH and DCT.
Where do thiazide diuretics act?
DCT
Where do K+-sparing diuretics act?
DCT and collecting duct.
Mannitol
MOA
Indication(s)
Adverse-effect(s)
MOA: osmotic diuretic causing increased tubular Osm.
Indication(s): drug overdose, elevated intraocular/intracranial pressure.
Adverse-effect(s): pulmonary edema, dehydration.
In which cases is mannitol contraindicated?
Patients with anuria and HF.
Acetazolamide
MOA
Indication(s)
Adverse-effect(s)
MOA: CA inhibitor leading to NaHCO3- diuresis and decreased HCO3- stores.
Indication(s): glaucoma, metabolic acidosis, altitude sickness, IIH.
Adverse-effect(s): RTA*, paresthesias, NH3 toxicity, sulfa allergies and calcium phosphate stone formation.
Loop diuretics
MOA
Indication(s)
Adverse-effect(s)
MOA: (1) inhibit Na+/K+/2Cl- in the TAL of the LoH; (2) stimulates PGE release (VD of AA); (3) increases Ca++ excretion.
Indication(s): edema, HTN and hypercalcemia.
Adverse-effect(s): Ototoxicity Hypokalemia Hypomagnesemia Dehydration Allergy (sulfa) metabolic Alkalosis Nephritis Gout
“OHHDANG”
What drugs are loop diuretics?
Furosemide, bumetanide, torsemide
“-ide”
What drug is used in patients allergic to sulfa, but would benefit from loop diuresis?
What adverse-effect is common with it?
Ethacrinic acid.
Ototoxicity
What drugs are thiazide diuretics?
Hydrochlorothiazide, chlorthalidone, metolazone
Thiazide diuretics
MOA
Indication(s)
Adverse-effect(s)
MOA: (1) inhibition of NaCl reabsorption in the early DCT, thus impairing the diluting capacity of the nephron; (2) decreased Ca++ excretion.
Indication(s): HTN. HF, idiopathic hypercalciuria, NDI, osteoporosis.
Adverse-effect(s): Hypokalemic metabolic alkalosis Hyponatremia Hyperglycemia Hyperlipidemia Hyperuricemia Hypercalcemia "HyperGLUC" Sulfa allergy
What drugs are K+-sparing diuretics?
“Keep your SEAT”
Spironolactone
Eplerone
Amiloride
Triamterene
K+-sparing diuretics
MOA
Indication(s)
Adverse-effect(s)
MOA: (1) competitive aldosterone inhibition at the collecting ducts (spironolactone, eplerone); (2) blockage of Na+ channels at the collecting ducts (amiloride, triamterene).
Indication(s): hyperaldosteronism, K+ depletion, HF, ascites, NDI, anti-androgen use.
Adverse-effect(s): hyperkalemia, endocrine effects with spironolactone (gynecomastia, anti-androgenic effects, etc.).